✦ LIBER ✦

Survival of patients with advanced hepatocellular carcinoma: Sorafenib versus other treatments

✍ Scribed by Hwi Young Kim; Joong-Won Park; Byung-Ho Nam; Hyun Keun Kim; Joon-Il Choi; Tae Hyun Kim; Hyun Beom Kim; Chang-Min Kim

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PR-104 plus sorafenib in patients with a

✍ Ghassan K. Abou-Alfa; Stephan L. Chan; Chia-Chi Lin; E. Gabriela Chiorean; Randa 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 180 KB

Prognostic factors in patients with adva

✍ M. Pinter; W. Sieghart; F. Hucke; I. Graziadei; W. Vogel; A. Maieron; R. Königsb 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

Safety and tolerance of sorafenib in Jap

✍ Sadahisa Ogasawara; Fumihiko Kanai; Shuntaro Obi; Shinpei Sato; Taketo Yamaguchi 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 182 KB

Computed tomography findings of sorafeni

✍ Min Ju Kim; Joon-Il Choi; Jong Seok Lee; Joong-Won Park 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 451 KB

Capecitabine plus cisplatin treatment in

✍ Manal M. Abdel Wahab; Lobna R. Ezz Elarab; Mohamed A. Ezz Elarab 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 382 KB

Phase I study of sorafenib in Japanese p

✍ Junji Furuse; Hiroshi Ishii; Kohei Nakachi; Eiichiro Suzuki; Satoshi Shimizu; Ke 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB